Provider
QP89-20 MHCP Pharmacy Benefit Exclusion for Viltepso®
Program effective Date: Sep 09, 2020
Search Results
Displaying 2551 - 2560 of 3661 results
Provider
QP86-20 Medical Drug Update for New to Market Tanezumab
Program effective Date: Sep 09, 2020
Provider
QP85-20 Commercial Pharmacy Benefit Exclusion for Tecartus™
Program effective Date: Sep 09, 2020
Provider
P70-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective November 2, 2020
Program effective Date: Sep 01, 2020
Provider
P67-20 Radiation Oncology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Sep 01, 2020
Provider
P66-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Sep 01, 2020
Provider
QP83-20 Preventive Care Outreach Campaign for ACA Individual and Small Group (with Carenet Health)
Program effective Date: Aug 26, 2020
Provider
QP81-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Risdiplam PA with QL
Program effective Date: Aug 26, 2020
Provider
QP79-20 Introducing the Blue Cross Blue Shield System’s New National High-Performance Network
Program effective Date: Aug 26, 2020
Provider
QP64R1-20 Medical Drug Update for New to Market Viltolarsen (Viltepso)
Program effective Date: Aug 26, 2020